Stelfonta
Stelfonta: How EBC-46 Conquered Canine Cancer and Changed the Course of Oncology Research
How EBC-46 became Stelfonta® — the first FDA and EMA approved intratumoral cancer treatment — through rigorous canine clinical trials, and what this milestone means for the ongoing Phase I/II human cancer trials.